Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension
Clinical trial NCT03948178 · TERMINATED
Trial details
- NCT number
- NCT03948178
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-26
- Primary completion
- 2020-11-18
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.